RhumbLine Advisers
CDAK

RhumbLine Advisers’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

RhumbLine Advisers’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,218
Closed -$83K – 3308
2022
Q1 		$83K Buy
+13,218
New +$83K ﹤0.01% 2921